Â÷ÀÇ°úÇдëÇб³ºÐ´çÂ÷º´¿ø ´ÜÀϱâ°ü POEM 300·Ê ±â³ä ½ÉÆ÷Áö¿ò : 2019-12-21±³À°ÀÏÀÚ : 2019-12-21
±³À°Àå¼Ò : B1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
´ÜÀϱâ°ü POEM 300·Ê ±â³ä ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : Â÷ÀÇ°úÇдëÇб³ºÐ´çÂ÷º´¿ø
´ã´çÀÚ : À¯Àΰæ
¿¬¶ôó : 031-780-1925
À̸ÞÀÏ :
chadm@chamc.co.kr ±³À°Á¾·ù : ³»°úÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, ¾à¸®ÇÐ, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ±âŸ
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
°æ±âµµ±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-08 B1Ãþ ´ë°´ç 13:30~13:50 »õ·Î¿î GERDÀÇ Áø´Ü ÃÖ¼®Ã¤(¿ø±¤´ë)
±³À°½Ã°£ 02-08 B1Ãþ ´ë°´ç 13:50~14:10 Pathophysiology and diagnosis of esophageal motility disorder ÀÌÅÂÈñ(¼øõÇâ´ë)
±³À°½Ã°£ 02-08 B1Ãþ ´ë°´ç 14:10~14:30 Endocopic Treatment of Chronic GERD °í¿øÁø(ÀÎÇÏ´ë)
±³À°½Ã°£ 02-08 B1Ãþ ´ë°´ç 14:30~14:50 POEM (E&G) ±è°æ¿À(ÀÎõ±æº´¿ø)
±³À°½Ã°£ 02-08 B1Ãþ ´ë°´ç 15:10~15:30 EUS-elastography for subepithelial lesions À¯Àΰæ(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 02-08 B1Ãþ ´ë°´ç 15:30~15:50 Contrast-Enhanced Transebdominal Sonography ÀÌÁÖÈ£(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 02-08 B1Ãþ ´ë°´ç 15:50~16:10 Revisited diagnostic value of PB EUS: classical and advanced method Á¶ÀçÈñ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 02-08 B1Ãþ ´ë°´ç 16:10~16:30 HCC immunotherapy and immuno-phenotype Nishida(Kindai ´ëÇб³)
±³À°½Ã°£ 02-08 B1Ãþ ´ë°´ç 16:30~16:50 TACE and levatinib combination therapy for intermediate HCC Ueshima(Kindai ´ëÇб³)
±³À°½Ã°£ 02-08 B1Ãþ ´ë°´ç 16:50~17:10 3. Immunotherapy for pancreatic cancer ±èµ¿¿í(ºÎ»ê´ë)
±³À°½Ã°£ 02-08 B1Ãþ ´ë°´ç 17:10~17:50 4. Intestinal enteroids/organoids: a novel platform for drug discovery in inflammatory bowel diseases À¯ÁØȯ(Â÷ÀÇ°úÇдë)